Paloma Partners Management CO Lannett CO Inc Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $231,590 - $349,431	-27,278 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $152,211 - $394,712	27,278 New	27,278 $306,000
Q1 2019 May 15, 2019	SELL	$5.35 - $9.82 $92,517 - $169,817	-17,293 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$3.43 - $6.19 $83,030 - $149,841	-24,207 Reduced 58.33%	17,293 $86,000
Q3 2018 Nov 14, 2018	BUY	$4.75 - $14.5 $117,576 - $358,918	24,753 Added 147.81%	41,500 $197,000
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $222,735 - $292,235	16,747 New	16,747 $228,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.